[Correspondence] SRS versus WBRT for resected brain metastases

We read with interest an article published in The Lancet Oncology by Paul Brown and colleagues.1 In this multicentre, randomised, controlled, phase 3 trial, Brown and colleagues aimed to establish the effect of stereotactic radiosurgery (SRS) on survival and cognitive outcomes compared with whole brain radiotherapy (WBRT) in patients with resected brain metastasis.

http://ift.tt/2xMGhMY